WallStSmart
COEP

Coeptis Therapeutics Inc

NASDAQ: COEP · HEALTHCARE · BIOTECHNOLOGY

$16.40
+1.17% today

Updated 2026-04-24

Market cap
$102.06M
P/E ratio
P/S ratio
74.88x
EPS (TTM)
$-2.81
Dividend yield
52W range
$7 – $21
Volume
0.0M

WallStSmart proprietary scores

23
out of 100
Grade: F
Strong Sell
Investment rating
6.3
Growth
B
5.0
Quality
C+
2.5
Profitability
F
6.7
Valuation
B
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$3.00
-81.71%
12-Month target
Intrinsic (DCF)
$57.26
Margin of safety
+79.06%

Price chart

X-Ray snapshot

Strengths
+ Revenue growth 1,564.00% QoQ
+ 79.06% below intrinsic value
Risks
- Thin margins at 0.00%
- Negative free cash flow $-1.69M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$1.36M$1.36M
Net income$-37.57M$-21.27M$-10.88M$-11.92M$-1.58M
EPS$-2.81
Free cash flow$-3.88M$-3.88M$-6.65M$-8.60M$-1.69M
Profit margin-874.29%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
COEP$102.06M236.32.56.75.0+79.06%Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Coeptis Therapeutics Inc trades at $16.40. Our Smart Value Score of 23/100 indicates the stock is weak. TTM revenue stands at $1.36M. Our DCF model estimates intrinsic value at $57.26.

Frequently asked questions

What is Coeptis Therapeutics Inc's stock price?
Coeptis Therapeutics Inc (COEP) trades at $16.40.
Is Coeptis Therapeutics Inc overvalued?
Smart Value Score 23/100 (Grade F, Strong Sell). DCF value $57.26.
What is the price target of Coeptis Therapeutics Inc (COEP)?
The analyst target price is $3.00, representing -81.7% downside from the current price of $16.40.
What is the intrinsic value of Coeptis Therapeutics Inc (COEP)?
Based on our DCF model, intrinsic value is $57.26, a +79.1% margin of safety versus $16.40.
What is Coeptis Therapeutics Inc's revenue?
TTM revenue is $1.36M.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio74.88x
ROE-136.90%
Beta-0.43
50D MA$12.26
200D MA$13.58
Shares out0.01B
Float0.01B
Short ratio
Avg volume0.0M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years